Published in
American Heart Association, Circulation, 2(144), p. 180-182, 2021
DOI: 10.1161/circulationaha.121.054034
Links
Tools
Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF
Journal article published in 2021 by
G. Michael Felker 
,
G. Michael Felker,
Javed Butler,
Nasiren E. Ibrahim,
Ileana L. Piña ,
Alan Maisel,
Devavrat Bapat,
Alexander Camacho,
Jonathan H. Ward,
Kristin M. Williamson,
Scott D. Solomon,
James L. Januzzi,
Investigators Prove Hf
,
G. Michael Felker,
Javed Butler,
Nasiren E. Ibrahim,
Ileana L. Piña ,
Alan Maisel,
Devavrat Bapat,
Alexander Camacho,
Jonathan H. Ward,
Kristin M. Williamson,
Scott D. Solomon,
James L. Januzzi,
Investigators Prove Hf
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 